Investor Presentaiton
24.
Investor presentation
Full year 2022
Sales growth of 16%, driven by both NAO and IO with 21% and
13% sales growth respectively
DKK
billion
Historic and reported sales by geography
Reported sales and growth breakdown
for the full year 2022
Novo NordiskⓇ
Regions
Sales
(mDKK)
Growth
Share of
growth
111.7
140.8
177.0
International Operations
85,847
13%
40%
13%
14%
14%
EMEA
44,236
15%
24%
10%
11%
9%
Region China
16,209
-6%
-4%
26%
25%
27%
ROW
25,402
24%
20%
North America Operations
91,107
21%
60%
52%
48%
52%
Hereof USA
84,656
19%
53%
Total sales
176,954
16%
100%
2017
North America
2021
EMEA
2022
Region China
ROW
Source: Quarterly company announcement
IO: International Operations; NAO: North American Operations; EMEA: Europe, Middle East, and Africa; RoW: Rest of World; Region China covers mainland China, Hong Kong and Taiwan
Note: Numbers may not add up to 100% due to rounding; Growth at Constant exchange rates; Sales numbers are reported in Danish kronerView entire presentation